Kelly White Email

VP Clinical and Medical Affairs . Fractyl

Current Roles

Employees:
107
Revenue:
$16.6M
About
Fractyl is a biotechnology firm dedicated to addressing metabolic disorders such as obesity and type 2 diabetes. This is accomplished through the development of novel therapies that target the underlying causes of these conditions, as opposed to merely treating their symptoms. Their primary emphasis is on the gastrointestinal tract and pancreas, with the objective of developing therapeutic interventions that rectify the fundamental pathology. Revita, a heat-based technique designed to enhance blood sugar regulation in diabetics, and Rejuva, an early-stage gene therapy platform, are both in their current pipeline. By doing so, they hope to revolutionize the treatment of metabolic diseases from chronic management to possible remedies, thereby saving lives and preventing the spread of these pervasive conditions. Check here for more information on how to align <a href="https://www.growthcollective.com/blog/4-steps-to-successfully-align-sales-marketing-teams-to-drive-revenue">sales and revenue</A>.
Fractyl Address
17 Hartwell Avenue
Lexington, null
Fractyl Email

Past Companies

FractylVice President, Clinical and Medical Affairs; Fractyl Laboratories, Inc.
FractylHead of Medical Affairs; Executive Director, Clinical Development
Self-employedConsultant, Medical and Scientific Communication and Training

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.